Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126546123 | 12654612 | 3 | F | 20160825 | 20160816 | 20160908 | EXP | US-AUROBINDO-AUR-APL-2016-10413 | AUROBINDO | 57.00 | YR | F | Y | 0.00000 | 20160908 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126546123 | 12654612 | 1 | PS | Vancomycin | VANCOMYCIN | 1 | Intravenous (not otherwise specified) | 1 G, EVERY 12 HOURS | Y | U | 205779 | 1 | G | ||||||
| 126546123 | 12654612 | 2 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 2 G, UNK | Y | U | 0 | 2 | G |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126546123 | 12654612 | 1 | Osteomyelitis |
| 126546123 | 12654612 | 2 | Osteomyelitis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126546123 | 12654612 | OT |
| 126546123 | 12654612 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126546123 | 12654612 | Acute kidney injury | |
| 126546123 | 12654612 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |